Novo Nordisk FDA - Search News

News

CEO of Novo Nordisk, Maker of Weight Loss Drug Wegovy

The New York Times · 1d

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Associated Press News on MSN · 1d

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

CBS News on MSN · 1d

Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual agreement."

FDA Accepts Novo Nordisk’s Application for Oral Wegovy: 5 Things to Know

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

1don MSN

Obesity drug maker Novo Nordisk ousts CEO as competition weighs

Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...

1don MSN

Novo Nordisk announces CEO transition as share price slips

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results